NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in Plug Power, Inc. (“Plug Power” or the “Company”) (NASDAQ:PLUG), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 3, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff ...

Core Viewpoint - Kirby McInerney LLP is investigating potential securities fraud claims against Arq, Inc. following the company's announcement to pause GAC production, which has led to a decline in its stock price [1][2]. Group 1: Investigation Details - The investigation focuses on whether Arq, Inc. and/or its senior management may have violated federal securities laws or engaged in unlawful business practices [1]. - On March 9, 2026, Arq announced a pause in GAC production to conduct a comprehensive review, resulting in no expected GAC production for fiscal year 2026, which negatively impacted the company's stock [2]. Group 2: Investor Actions - Investors who purchased or acquired Arq securities and have information related to the investigation are encouraged to contact Kirby McInerney LLP to discuss their rights or interests at no cost [3].

Core Viewpoint - A securities fraud class action lawsuit has been filed against PayPal Holdings, Inc. for allegedly making materially false and misleading statements regarding its business operations and revenue outlook during the specified class period [1][3][5]. Summary by Relevant Sections Lawsuit Details - The class action lawsuit pertains to investors who purchased PayPal common stock between February 25, 2025, and February 2, 2026, with a deadline of April 20, 2026, to file for lead plaintiff status [1][5]. - The complaint alleges that PayPal's management misrepresented the company's projected revenue and growth, creating a false impression of stability and reliability [3][5]. Stock Performance - On February 3, 2026, PayPal announced a leadership change, replacing its CEO, which coincided with the release of its fourth quarter and full year 2025 earnings report. The company missed consensus estimates for both revenue and profit, leading to a stock price drop of $10.63, or 20.3%, closing at $41.70 per share [4]. Investor Actions - Investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for recovery options at no cost. They can seek to be appointed as lead plaintiff representatives or remain absent class members [2][8][13].

Core Viewpoint - The Snowflake Inc. class action lawsuit alleges that the company and certain former executives made misleading statements regarding product efficiency and revenue forecasts, leading to significant stock price declines [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Patel v. Snowflake Inc. and is filed in the Northern District of California, with a class period from June 27, 2023, to February 28, 2024 [1]. - Investors who purchased Snowflake Class A common stock during the class period have until April 27, 2026, to seek appointment as lead plaintiff [1]. - The lawsuit claims that Snowflake's product efficiency gains and tiered storage pricing were expected to negatively impact consumption and revenues, casting doubt on the company's ability to reach $10 billion in revenue by 2029 [3]. Group 2: Financial Impact - On February 28, 2024, Snowflake announced financial results indicating increased revenue headwinds due to product efficiency gains and tiered storage pricing, resulting in an over 18% drop in the stock price [4]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is representing investors in this class action lawsuit, which is part of their broader focus on securities fraud and shareholder rights litigation [6].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Driven Brands Holdings Inc. for alleged material misstatements and omissions regarding its financial reporting and internal controls, affecting investors who purchased shares between May 9, 2023, and February 24, 2026 [2][4][6]. Summary by Relevant Sections Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York, under the case name Clark v. Driven Brands Holdings Inc., with a deadline for investors to file for lead plaintiff status set for May 8, 2026 [2][6]. - The allegations include errors in lease recording, cash balance reporting, and misclassification of expenses, which led to overstatements of cash and revenue for fiscal years 2023 and 2024 [4][5]. Financial Impact - Driven Brands announced on February 25, 2026, that it would restate its financial statements for fiscal years 2023 and 2024, as well as for 2025, due to identified accounting errors, resulting in a stock price drop of $5.01 per share, nearly 40%, from $16.61 to $11.60 [5]. Investor Actions - Investors who purchased Driven Brands common stock and incurred losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for recovery options at no cost [3][6]. - Investors have the option to seek lead plaintiff status or remain as absent class members, with the lead plaintiff representing the interests of the class in the litigation [7][11]. Law Firm Background - Kessler Topaz Meltzer & Check, LLP is a recognized law firm specializing in securities fraud class actions, having recovered over $25 billion for clients and institutions [9].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Soleno Therapeutics, Inc. for allegedly making materially false statements regarding its Phase 3 clinical trial program for its product DCCR, which is intended for treating hyperphagia in individuals with Prader-Willi syndrome [2][5][6]. Company Overview - Soleno Therapeutics, Inc. is a pharmaceutical company based in Redwood City, California, focused on developing therapies for rare diseases. Its only commercial product is diazoxide choline extended-release tablets (DCCR) [4]. Lawsuit Details - The lawsuit is filed in the United States District Court for the Northern District of California, with the case captioned City of Pontiac Police and Fire Retirement System v. Soleno Therapeutics, Inc., et al, Case No. 3:26-cv-01979 (N.D. Cal.) [2]. - Investors who purchased Soleno common stock between March 26, 2025, and November 4, 2025, are eligible to seek lead plaintiff status by May 5, 2026 [2][8]. Allegations - The complaint alleges that Soleno's executives misrepresented and failed to disclose significant safety concerns related to DCCR, including issues of excess fluid retention in clinical trial participants [5]. - It is claimed that the administration of DCCR posed greater safety risks than disclosed, leading to lower commercial viability and potential adverse events post-launch [5]. - The lawsuit highlights that the company's statements regarding its business and operations were materially false and misleading throughout the class period [5]. Stock Performance - Following the release of financial results on November 4, 2025, and a report by Scorpion Capital, Soleno's stock price dropped over 26%, attributed to concerns raised about the DCCR launch trajectory and clinical trial issues [6][7].

Core Viewpoint - Inovio Pharmaceuticals, Inc. is facing a securities fraud lawsuit, with a lead plaintiff deadline set for April 7, 2026, for investors who purchased securities during the specified class period from October 10, 2023, to December 26, 2025 [1]. Group 1: Lawsuit Details - The lawsuit alleges that during the class period, Inovio made false and misleading statements regarding the manufacturing of its CELLECTRA device and the likelihood of submitting the INO-3107 Biologics License Application (BLA) to the FDA by the second half of 2024 [5]. - It is claimed that Inovio lacked sufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review, leading to overstated regulatory and commercial prospects [5]. - The lawsuit asserts that when the true details became public, investors suffered damages due to the misleading statements made by the defendants [5]. Group 2: Class Action Participation - Investors who purchased Inovio securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - A class has not yet been certified, meaning investors are not represented by counsel unless they retain one, and participation as a lead plaintiff is not necessary for potential recovery [7].

Core Viewpoint - The Camping World Holdings, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements and inadequate disclosures regarding its financial health and inventory management practices [1][3]. Company Allegations - The lawsuit alleges that Camping World overstated its inventory management capabilities and retail demand, which led to a need for corrective inventory management that negatively impacted gross profit and margins [3]. - Specific allegations include that Camping World failed to disclose its inadequate systems for ensuring accurate financial disclosures and guidance regarding its balance sheet and operational expenses [3]. Financial Performance - In the third quarter of 2025, Camping World reported new vehicle revenue of $766.8 million, a decrease of $58.1 million or 7.0%, with the average selling price of new vehicles sold decreasing by 8.6% [4]. - The gross margin for new vehicles was reported at 12.7%, down 81 basis points, primarily due to the decrease in average selling price [4]. - Following the release of these results, Camping World shares fell nearly 25% [4]. - In the fourth quarter of 2025, the company announced strict inventory management objectives and paused its quarterly cash dividend, which led to a further decline in share price of more than 16% [5]. Legal Process - Investors who purchased Camping World securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [6]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect the ability to share in any potential recovery [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [7]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, making it one of the largest plaintiffs' firms globally [7][8].

Core Viewpoint - The lawsuit against Trip.com Group Limited alleges that the company understated regulatory risks related to its monopolistic practices, impacting investors who purchased securities during the specified class period [4]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of investors who bought Trip.com securities from April 30, 2024, to January 13, 2026 [4]. - The lawsuit claims that Trip.com recklessly understated the regulatory risks associated with its business activities [4]. - Investors have until May 11, 2026, to apply for lead plaintiff status, which allows them to oversee the litigation and influence key decisions [2]. Group 2: Impact of Regulatory Investigation - On January 14, 2026, Trip.com disclosed it received a notice of investigation regarding China's Anti-Monopoly Law, leading to a significant drop in share price [5]. - Following the announcement, Trip.com shares fell by $12.90, or approximately 17.1%, from $75.68 to $62.78 [5].

ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit Accessibility StatementSkip NavigationNEW YORK, March 18, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the C ...